Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Booth

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 1996
Inhibitors of fibrinolysis are elevated in atherosclerotic plaqueL A Robbie, N A Booth, A J Brown, et al.
Thrombosis and Haemostasis|August 2, 1993
The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysisL A Robbie, N A Booth, A M Croll, et al.
Thrombosis and Haemostasis|March 1, 1997
Thrombi formed in a Chandler loop mimic human arterial thrombi in structure and RAI-1 content and distributionL A Robbie, S P Young, B Bennett, et al.
British Journal of Haematology|December 21, 2000
Effective lysis of model thrombi by a t-PA mutant (A473S) that is resistant to alpha2-antiplasminL A Robbie, B Bennett, B A Keyt, et al.
Journal of Thrombosis and Haemostasis : JTH|August 28, 2003
Thrombus lysis by uPA, scuPA and tPA is regulated by plasma TAFIN J Mutch, N R Moore, E Wang, et al.
European Journal of Biochemistry|August 15, 1994
Purification and characterization of active and stable recombinant plasminogen-activator inhibitor accumulated at high levels in Escherichia coliE Sancho, D W Tonge, R C Hockney, et al.
Annals of the New York Academy of Sciences|July 20, 2001
Characterization of crosslinking sites in fibrinogen for plasminogen activator inhibitor 2 (PAI-2)H Ritchie, L C Lawrie, M W Mosesson, et al.
British Journal of Haematology|August 1, 1990
The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in diseaseA J Simpson, N A Booth, N R Moore, et al.
European Journal of Biochemistry|June 15, 1987
Plasminogen activator inhibitor from human endothelial cells. Purification and partial characterizationN A Booth, I R MacGregor, N R Hunter, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1991
Metformin causes a reduction in basal and post-venous occlusion plasminogen activator inhibitor-1 in type 2 diabetic patientsP J Grant, M H Stickland, N A Booth, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 1996
Inhibitors of fibrinolysis are elevated in atherosclerotic plaqueL A Robbie, N A Booth, A J Brown, et al.
Thrombosis and Haemostasis|August 2, 1993
The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysisL A Robbie, N A Booth, A M Croll, et al.
Thrombosis and Haemostasis|March 1, 1997
Thrombi formed in a Chandler loop mimic human arterial thrombi in structure and RAI-1 content and distributionL A Robbie, S P Young, B Bennett, et al.
British Journal of Haematology|December 21, 2000
Effective lysis of model thrombi by a t-PA mutant (A473S) that is resistant to alpha2-antiplasminL A Robbie, B Bennett, B A Keyt, et al.
Journal of Thrombosis and Haemostasis : JTH|August 28, 2003
Thrombus lysis by uPA, scuPA and tPA is regulated by plasma TAFIN J Mutch, N R Moore, E Wang, et al.
European Journal of Biochemistry|August 15, 1994
Purification and characterization of active and stable recombinant plasminogen-activator inhibitor accumulated at high levels in Escherichia coliE Sancho, D W Tonge, R C Hockney, et al.
Annals of the New York Academy of Sciences|July 20, 2001
Characterization of crosslinking sites in fibrinogen for plasminogen activator inhibitor 2 (PAI-2)H Ritchie, L C Lawrie, M W Mosesson, et al.
British Journal of Haematology|August 1, 1990
The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in diseaseA J Simpson, N A Booth, N R Moore, et al.
European Journal of Biochemistry|June 15, 1987
Plasminogen activator inhibitor from human endothelial cells. Purification and partial characterizationN A Booth, I R MacGregor, N R Hunter, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1991
Metformin causes a reduction in basal and post-venous occlusion plasminogen activator inhibitor-1 in type 2 diabetic patientsP J Grant, M H Stickland, N A Booth, et al.
Pageof 9